Susquehanna International Group’s Anixa Biosciences ANIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $55.5K | Sell |
16,803
-178,368
| -91% | -$589K | ﹤0.01% | 6014 |
|
|
2025
Q1 | $558K | Sell |
195,171
-86,522
| -31% | -$247K | ﹤0.01% | 4200 |
|
|
2024
Q4 | $654K | Buy |
281,693
+185,345
| +192% | +$430K | ﹤0.01% | 3652 |
|
|
2024
Q3 | $303K | Sell |
96,348
-16,045
| -14% | -$50.5K | ﹤0.01% | 4282 |
|
|
2024
Q2 | $248K | Sell |
112,393
-228,558
| -67% | -$505K | ﹤0.01% | 4445 |
|
|
2024
Q1 | $1.06M | Buy |
340,951
+267,648
| +365% | +$835K | ﹤0.01% | 2556 |
|
|
2023
Q4 | $284K | Buy |
73,303
+36,645
| +100% | +$142K | ﹤0.01% | 4583 |
|
|
2023
Q3 | $120K | Sell |
36,658
-10,600
| -22% | -$34.7K | ﹤0.01% | 4844 |
|
|
2023
Q2 | $151K | Sell |
47,258
-108,526
| -70% | -$347K | ﹤0.01% | 4798 |
|
|
2023
Q1 | $670K | Buy |
155,784
+84,761
| +119% | +$364K | ﹤0.01% | 3438 |
|
|
2022
Q4 | $302K | Buy |
71,023
+31,115
| +78% | +$132K | ﹤0.01% | 3882 |
|
|
2022
Q3 | $196K | Buy |
39,908
+22,119
| +124% | +$109K | ﹤0.01% | 4816 |
|
|
2022
Q2 | $54K | Buy |
+17,789
| New | +$54K | ﹤0.01% | 5216 |
|
|
2022
Q1 | – | Sell |
-19,300
| Closed | -$57K | – | 5703 |
|
|
2021
Q4 | $57K | Sell |
19,300
-26,606
| -58% | -$78.6K | ﹤0.01% | 5438 |
|
|
2021
Q3 | $219K | Buy |
45,906
+29,000
| +172% | +$138K | ﹤0.01% | 4613 |
|
|
2021
Q2 | $66K | Buy |
+16,906
| New | +$66K | ﹤0.01% | 5127 |
|
|
2015
Q4 | – | Sell |
-11,103
| Closed | -$53K | – | 4207 |
|
|
2015
Q3 | $53K | Buy |
+11,103
| New | +$53K | ﹤0.01% | 4034 |
|